Press Release: Euclises : Euclises Pharmaceuticals to Present at Biotech Showcase in San Francisco
ST. LOUIS--(BUSINESS WIRE)--Euclises Pharmaceutical's lead oncology candidate, a novel COX-2 inhibitor, to be presented at the 8th Annual Biotech Showcase 2016 conference on January 13, 2016, by CEO Bobby Sandage.
Read full article »
Euclises Pharmaceuticals engages in oncology drug development and cancer therapy.
Read more